Antiproliferative and apoptotic potential of methotrexate lipid nanoparticles in a murine breast cancer model.
Nanomedicine (Lond)
; 17(11): 753-764, 2022 05.
Article
em En
| MEDLINE
| ID: mdl-35575008
ABSTRACT
Aim:
To evaluate the efficacy of novel methotrexate-loaded nanoparticles (MTX-NPs) in vitro and in vivo in the treatment of breast cancer. Materials &methods:
MTX-NPs were tested for cellular uptake, cell viability, cell cycle, cellular wound migration and changes in tumor volume using characterized NPs.Results:
The solid lipid NPs (SLNPs) showed strong cellular uptake, increased apoptosis, controlled cytotoxicity at lower IC50 of methotrexate and a sizable reduction in tumor burden.Conclusion:
MTX-NP oral formulation can be a promising candidate in breast cancer treatment with improved cellular uptake and in vivo efficacy.Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Neoplasias da Mama
/
Nanopartículas
Limite:
Animals
/
Female
/
Humans
Idioma:
En
Ano de publicação:
2022
Tipo de documento:
Article